Cargando…
Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648339/ https://www.ncbi.nlm.nih.gov/pubmed/26692782 http://dx.doi.org/10.1080/13102818.2014.933500 |
_version_ | 1782401218532868096 |
---|---|
author | Avramov, Toma Vetckova, Evelina Nikolova, Maria Valev, Dinko Manolova, Antoaneta Tafradgiiska, Maya Kostadinov, Dimitar Tchalacov, Ivan |
author_facet | Avramov, Toma Vetckova, Evelina Nikolova, Maria Valev, Dinko Manolova, Antoaneta Tafradgiiska, Maya Kostadinov, Dimitar Tchalacov, Ivan |
author_sort | Avramov, Toma |
collection | PubMed |
description | Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including surgical, conservative and combined approaches. A total of 43 patients with papillomatosis that received a combined therapy were followed in the period from 2009 to 2013. The treatment included electrosurgery and CO(2) laser surgery alongside with either immunotherapy with Bacillus Calmette-Guerin (BCG) (Calgevax) or α-interferon. In the control group without immunotherapy (n = 16) we used conventional microlaryngeal surgery. During the follow-up, relapse occurred in two patients for the CO(2) laser surgery with Calgevax immunotherapy group (n = 16). In the group treated with α-interferon preceded by CO(2) laser surgery (n = 9) and electrosurgery (n = 2), relapse had occurred in three patients. Among the control group, recurrence was observed in six patients. This required re-operation. Our data showed a three times more frequent relapses among patients who were operated with conventional surgery as compared to those operated with CO(2) laser surgery and Calgevax immunotherapy, and two times more often relapses in patients operated with conventional surgery as compared to those with electrosurgery and CO(2) laser surgery and application of α-interferon therapy. Conventional and laser surgeries have a palliative effect, though playing an important role in ensuring the airway patency. While specific antivirus treatment for human papilloma viruses does not exist, the immune modulation with Calgevax considerably reduces the frequency of relapses, by stimulating cellular immune effector mechanisms. The combined protocol allows rarefication of relapses and improvement of patients’ quality of life, but not complete healing. |
format | Online Article Text |
id | pubmed-4648339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-46483392015-12-10 Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) Avramov, Toma Vetckova, Evelina Nikolova, Maria Valev, Dinko Manolova, Antoaneta Tafradgiiska, Maya Kostadinov, Dimitar Tchalacov, Ivan Biotechnol Biotechnol Equip Article; Medical Biotechnology Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including surgical, conservative and combined approaches. A total of 43 patients with papillomatosis that received a combined therapy were followed in the period from 2009 to 2013. The treatment included electrosurgery and CO(2) laser surgery alongside with either immunotherapy with Bacillus Calmette-Guerin (BCG) (Calgevax) or α-interferon. In the control group without immunotherapy (n = 16) we used conventional microlaryngeal surgery. During the follow-up, relapse occurred in two patients for the CO(2) laser surgery with Calgevax immunotherapy group (n = 16). In the group treated with α-interferon preceded by CO(2) laser surgery (n = 9) and electrosurgery (n = 2), relapse had occurred in three patients. Among the control group, recurrence was observed in six patients. This required re-operation. Our data showed a three times more frequent relapses among patients who were operated with conventional surgery as compared to those operated with CO(2) laser surgery and Calgevax immunotherapy, and two times more often relapses in patients operated with conventional surgery as compared to those with electrosurgery and CO(2) laser surgery and application of α-interferon therapy. Conventional and laser surgeries have a palliative effect, though playing an important role in ensuring the airway patency. While specific antivirus treatment for human papilloma viruses does not exist, the immune modulation with Calgevax considerably reduces the frequency of relapses, by stimulating cellular immune effector mechanisms. The combined protocol allows rarefication of relapses and improvement of patients’ quality of life, but not complete healing. Taylor & Francis 2014-07-04 2014-10-28 /pmc/articles/PMC4648339/ /pubmed/26692782 http://dx.doi.org/10.1080/13102818.2014.933500 Text en © 2014 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Article; Medical Biotechnology Avramov, Toma Vetckova, Evelina Nikolova, Maria Valev, Dinko Manolova, Antoaneta Tafradgiiska, Maya Kostadinov, Dimitar Tchalacov, Ivan Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title | Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title_full | Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title_fullStr | Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title_full_unstemmed | Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title_short | Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
title_sort | therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) |
topic | Article; Medical Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648339/ https://www.ncbi.nlm.nih.gov/pubmed/26692782 http://dx.doi.org/10.1080/13102818.2014.933500 |
work_keys_str_mv | AT avramovtoma therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT vetckovaevelina therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT nikolovamaria therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT valevdinko therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT manolovaantoaneta therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT tafradgiiskamaya therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT kostadinovdimitar therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy AT tchalacovivan therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy |